- Home
- EVAX vs COSM Comparison
EVAX vs COSM Comparison
Compare EVAX & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- COSM
- Stock Information
- Founded
- EVAX 2008
- COSM 2009
- Country
- EVAX Denmark
- COSM United States
- Employees
- EVAX N/A
- COSM N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- COSM Other Pharmaceuticals
- Sector
- EVAX Health Care
- COSM Health Care
- Exchange
- EVAX Nasdaq
- COSM Nasdaq
- Market Cap
- EVAX 16.3M
- COSM 18.4M
- IPO Year
- EVAX 2021
- COSM 2013
- Fundamental
- Price
- EVAX $2.53
- COSM $0.62
- Analyst Decision
- EVAX Strong Buy
- COSM
- Analyst Count
- EVAX 3
- COSM 0
- Target Price
- EVAX $33.33
- COSM N/A
- AVG Volume (30 Days)
- EVAX 6.8M
- COSM 397.6K
- Earning Date
- EVAX 03-26-2025
- COSM 11-14-2024
- Dividend Yield
- EVAX N/A
- COSM N/A
- EPS Growth
- EVAX N/A
- COSM N/A
- EPS
- EVAX N/A
- COSM N/A
- Revenue
- EVAX $3,295,000.00
- COSM $56,042,109.00
- Revenue This Year
- EVAX $9,039.73
- COSM $4.53
- Revenue Next Year
- EVAX $1.47
- COSM $25.00
- P/E Ratio
- EVAX N/A
- COSM N/A
- Revenue Growth
- EVAX N/A
- COSM 13.01
- 52 Week Low
- EVAX $2.22
- COSM $0.47
- 52 Week High
- EVAX $22.05
- COSM $1.58
- Technical
- Relative Strength Index (RSI)
- EVAX 40.91
- COSM 40.41
- Support Level
- EVAX $2.43
- COSM $0.60
- Resistance Level
- EVAX $2.80
- COSM $0.67
- Average True Range (ATR)
- EVAX 0.31
- COSM 0.07
- MACD
- EVAX 0.07
- COSM -0.01
- Stochastic Oscillator
- EVAX 16.94
- COSM 6.77
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.